ACE OncoCast Podcast Artwork Image

ACE OncoCast

ACE Oncology

The official podcast feed of ACE Oncology. ACE provides evidence-based, high-quality independent medical education solutions that support clinicians in making up-to-date, appropriate treatment decisions. Listen to discussions among experts and stay informed on new data and best practices in the care of patients with cancer. The information in this podcast is provided for informational and educational purposes only.
Episodes
Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer 4: Novel Drugs in DevelopmentJanuary 16, 2024
Episode artwork
Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer 3: Second/subsequential Treatment Decision-making January 16, 2024
Episode artwork
Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer 1: First-line Treatment Decision-makingJanuary 16, 2024
Episode artwork
Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer 2: First-line Maintenance Treatment Decision-makingJanuary 16, 2024
Episode artwork
Expert Interview: Frequently Asked Questions (FAQs) for Second Line (2L) and Salvage TreatmentsNovember 03, 2023
Episode artwork
Expert Interview: Frequently Asked Questions (FAQs) for Muscle Invasive Bladder Cancer (MIBC)November 03, 2023
Episode artwork
Expert Interview: Frequently Asked Questions (FAQs) for Non Muscle Invasive Bladder Cancer (NMIBC)November 03, 2023
Episode artwork
Expert Interview: Frequently Asked Questions (FAQs) for First Line (1L) Treatment Decision makingNovember 03, 2023
Episode artwork
Personalized therapy in SCLC: Promises and challengesDecember 14, 2022
Episode artwork
Closer look at the biology of SCLC and molecular subtypesDecember 14, 2022
Episode artwork
Current standard of care for ES SCLCDecember 14, 2022
Episode artwork
Second-line and salvage treatments for metastatic urothelial cancerDecember 09, 2022
Episode artwork
First-line treatment of advanced metastatic urothelial cancerDecember 09, 2022
Episode artwork
Locally advanced diseaseDecember 09, 2022
Episode artwork
Targeting KRAS G12C MutationsOctober 02, 2022
Episode artwork
Targeting Rare Molecular DriversOctober 01, 2022
Episode artwork
Detection of Osimertinib Resistance and Targeting MET AmplificationSeptember 30, 2022
Episode artwork
Targeted Therapy in Early-Stage EGFR-Mutated NSCLC September 29, 2022
Episode artwork
Updates on Oncogene-Driven NSCLC from Vienna: Osimertinib resistanceAugust 14, 2022
Episode artwork
Updates on Oncogene-Driven NSCLC from Vienna: Targeting KRAS G12C mutationAugust 13, 2022
Episode artwork
Updates on Oncogene-Driven NSCLC from Vienna: Targeting METex 14 skipping mutationsAugust 12, 2022
Episode artwork
Promising Strategies to Enhance Efficacy of (Chemo)radiotherapy in LA SCCHNJune 29, 2022
Episode artwork
The Role of Immunotherapy in LA SCCHNJune 22, 2022
Episode artwork
Current Standard of Care for LA SCCHNJune 15, 2022
Episode artwork
Best Practice Exchange in advanced UC - Clinical case 2: Immunotherapy adverse event managementMarch 16, 2022
Episode artwork